This opportunity is no longer accepting applications.
grant RFA-AG-25-032

Consortium for Neuroscience AD/ADRD in Low- and Middle-Income Countries (U01 Clinical Trial Not Allowed)

This grant opportunity supports collaborative research between experienced investigators in low- and middle-income countries (LMICs) and the United States, focusing on Alzheimer's disease and related dementias like frontotemporal dementia and Lewy body dementia. The research aims to build sustainable capacity in neuroscience and develop strategies for prevention and mitigation of these disease…

This notice of funding opportunity (NOFO) promotes collaborative research programs to support innovative and sustainable Alzheimer's disease (AD) and AD-related dementias (AD/ADRD) (including frontotemporal dementia (FTD), Lewy body dementia (LBD), vascular cognitive impairment/dementia (VCID), …

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute on Aging

Awards & funding

Award Ceiling: $400,000
Award Amount: $400,000

Dates

Opportunity Released: September 6, 2024
Open for Submission: September 6, 2024
Submission Deadline: February 14, 2025
Application Window Closes: February 14, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.